Abbott Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Financial Outlook

Abbott projects full-year 2026 organic sales growth to be in the range of 6.5% to 7.5%. Abbott projects full-year 2026 adjusted diluted earnings per share of $5.55 to $5.80 and first-quarter 2026 ...

Abbott misses quarterly revenue estimates on weakness in diagnostics segment

Abbott missed Wall Street estimates for quarterly revenue on Thursday, hit by weakness in its diagnostic business which has ...

Abbott Labs Stock Hits 52-Week Low As Outlook Disappoints

Abbott shares fell after quarterly sales and early 2026 earnings guidance missed estimates, even as the company forecast ...
Investing.com South Africa

Abbott falls as fourth quarter revenue misses expectations

Investing.com -- Abbott Laboratories (NYSE:ABT) reported fourth-quarter earnings that met expectations but missed on revenue, ...
Becker's Hospital Review

Not so fast: Abbott rapid COVID-19 test raises concerns for safety of its handlers

Lab officials say Abbott’s rapid COVID-19 test poses a greater risk of infection to those administering it than other types of diagnostic tests, Kaiser Health News reported. HHS has said the test ...
Reuters

U.S. regulator is reviewing Abbott's fast COVID test after studies raise accuracy concerns

(Reuters) - The U.S. Food and Drug Administration said on Thursday that Abbott Laboratories’ speedy coronavirus test, which can deliver results within minutes and is used at the White House, could ...
ABC 7 Chicago

Coronavirus Illinois testing: Abbott Laboratories prepares to roll out COVID-19 test

CHICAGO (WLS) -- A new COVID19 test that provides results in five minutes is set to roll out soon as Illinois-based Abbott Labs expected to deliver 50,000 tests per-day. President Donald Trump did a ...